Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective Study

Autor:	Hernández S, Navas E, Aznar, I., Ciruela P, García-García JJ, Moraga-Llop F, Munoz-Almagro C, Codina G, Fernández de Sevilla-Estrach M, González-Peris S, Esteva-Afonso C, Planes AM, Izquierdo C, Johanna Martínez Osorio, Campins M, Uriona S, Salleras L, Serrano-Blanco A, Jané M, Domínguez A
Rok vydání:	2020
Předmět:	PCV13 PCV7 direct cost invasive pneumococcal disease bacterial infections and mycoses health care economics and organizations
Zdroj:	Vaccines r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu instname r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
ISSN:	2076-393X
Popis:	The lack of invasive pneumococcal disease (IPD) cost studies may underestimate the effect of pneumococcal polysaccharide conjugated vaccines (PCV). The objective of this study was to estimate the direct costs of hospitalized IPD cases. A prospective study
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::918f17035f5d5bc869d13113f4f172e0 http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17958 Zobrazit plný text záznamu